ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit

Follow on social Media
SSO2 Animation for Clinicians | SuperSaturated Oxygen Therapy for Acute Myocardial Infarct | TherOx
TherOx has developed a proprietary medical technology called SuperSaturated Oxygen (SSO2) Therapy. SSO2 Therapy creates a highly oxygenated saline solution and combines it with the patient’s arterial blood to provide focal hyperoxemic oxygen therapy to ischemic (oxygen-deprived) tissue. The focus of SSO2 Therapy is for the treatment of acute myocardial infarction (heart attack).
Cardiac Diagnostics ZOLL CDX Physician
LifeVest Heart Failure
Thermogard XP
TherOx Why Consider SSO2 Therapy